이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2012. 8. 3.1 분 읽기
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →